Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

(MedPage Today) -- NEW ORLEANS -- Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase II randomized trials showed. In the dose...
Source
MedPage Today
Opens original article in a new tab



